Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9266813
APP PUB NO 20140303241A1
SERIAL NO

14229339

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a series of derivatives of stilbenoid which are useful as new inhibitory agents against head and neck squamous cell carcinoma (HNSCC) and hepatoma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHINA MEDICAL UNIVERSITYTAICHUNG 40402

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chang, Ling-Chu Taichung, TW 4 2
Chen, Huei-Wen Taichung, TW 7 3
Cheng, Yung-Yi Taichung, TW 1 0
Hsieh, Min-Tsang Taichung, TW 4 1
Huang, Li-Jiau Taichung, TW 12 76
Hung, Hsin-Yi Taichung, TW 4 1
Kuo, Sheng-Chu Taichung, TW 57 348
Lee, Kuo-Hsiung Taichung, TW 71 461
Lin, Hui-Yi Taichung, TW 17 116
Liu, Chin-Yu Taichung, TW 4 4
Way, Tzong-Der Taichung, TW 12 4
Wu, Tian-Shung Taichung, TW 24 52
Yang, Jai-Sing Taichung, TW 11 7

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 23, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00